OR WAIT null SECS
July 30, 2021
Emergent BioSolutions is being allowed to restart manufacturing operations for the J&J COVID-19 vaccine at its Bayview, Baltimore, Md., facility.
July 13, 2021
Moderna announces supply agreement with the Argentina government for 20 million doses of Moderna’s COVID-19 vaccine.
July 02, 2021
HHS is tasked with establishing a public-private consortium for advanced domestic pharmaceutical production.
June 28, 2021
Pharmaceutical Technology discussed the potential increased risk of counterfeit medicines in the UK post-Brexit and how blockchain could be a useful tool to tackle the issue.
June 11, 2021
Roambee has acquired Modum, a Swiss pharma last mile-focused cold chain monitoring player, expanding its cold chain visibility capabilities.
June 08, 2021
The agency issued two final and two draft guidance documents to help identify and trace drug products in the supply chain.
June 03, 2021
Eight companies representing the pharmaceutical supply chain have joined a newly founded non-profit membership association, Alliance to Zero, aimed at facilitating the transition of the pharma sector to comply with net-zero emissions.
May 20, 2021
USP worked with a patient advocacy group and a purchasing organization to create a predictive model for improving supply chain resilience for critical pediatric oncology drugs.
May 15, 2021
Supply-chain visibility systems are proving their worth in the distribution of COVID-19 vaccines and may see broader use in the future.
May 03, 2021
Breakthroughs in analytics and alternatives to traditional freeze drying promise to reshape biological development and the cold chain.